Literature DB >> 10601070

Gene therapy of hepatic diseases: prospects for the new millennium.

K Shetty1, G Y Wu, C H Wu.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10601070      PMCID: PMC1727783          DOI: 10.1136/gut.46.1.136

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  35 in total

1.  Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.

Authors:  J M Wilson; N R Chowdhury; M Grossman; R Wajsman; A Epstein; R C Mulligan; J R Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Codelivery to mammalian cells of a transcriptional factor with cis-acting element using cationic liposomes.

Authors:  H Farhood; X Gao; J Barsoum; L Huang
Journal:  Anal Biochem       Date:  1995-02-10       Impact factor: 3.365

3.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Authors:  Y Yang; Q Li; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

Authors:  T VandenDriessche; V Vanslembrouck; I Goovaerts; H Zwinnen; M L Vanderhaeghen; D Collen; M K Chuah
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.

Authors:  J Herz; R D Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Virus-directed enzyme/prodrug therapy (VDEPT). Selectively engineering drug sensitivity into tumors.

Authors:  B E Huber; C A Richards; E A Austin
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

Review 7.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

8.  Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.

Authors:  H A Jaffe; C Danel; G Longenecker; M Metzger; Y Setoguchi; M A Rosenfeld; T W Gant; S S Thorgeirsson; L D Stratford-Perricaudet; M Perricaudet
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

9.  Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Authors:  Y Yang; F A Nunes; K Berencsi; E Gönczöl; J F Engelhardt; J M Wilson
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

10.  In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

Authors:  W B Offensperger; S Offensperger; E Walter; K Teubner; G Igloi; H E Blum; W Gerok
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  3 in total

Review 1.  Gene therapy for brain tumors.

Authors:  K Bansal; H H Engelhard
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Hydrodynamics-based transfection of rat interleukin-10 gene attenuates porcine serum-induced liver fibrosis in rats by inhibiting the activation of hepatic stellate cells.

Authors:  Yue-Hong Huang; Yun-Xin Chen; Li-Juan Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  Int J Mol Med       Date:  2014-07-02       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.